Literature DB >> 27366679

Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.

Jun Shao1, Yong Yao1.   

Abstract

AIM: To investigate biological effects of transthyretin (TTR) on the development of neovascularization under simulated diabetic retinopathy (DR) condition associated with high glucose and hypoxia.
METHODS: Human retinal microvascular endothelial cells (hRECs) were cultured in normal and simulated DR environments with high glucose and hypoxia. The normal serum glucose concentration is approximately 5.5 mmol/L; thus, hyperglycemia was simulated with 25 mmol/L glucose, while hypoxia was induced using 200 µmol/L CoCl2. The influence of TTR on hRECs and human retinal pigment epithelial cells (hRPECs) was determined by incubating the cells with 4 µmol/L TTR in normal and abnormal media. A co-culture system was then employed to evaluate the effects of hRPECs on hRECs.
RESULTS: Decreased hRECs and hRPECs were observed under abnormal conditions, including high-glucose and hypoxic media. In addition, hRECs were significantly inhibited by 4 µmol/L exogenous TTR during hyperglycemic culture. During co-culture, hRPECs inhibited hRECs in both the normal and abnormal environments.
CONCLUSION: hREC growth is inhibited by exogenous TTR under simulated DR environments with high-glucose and hypoxic, particularly in the medium containing 25 mmol/L glucose. hRPECs, which manufacture TTR in the eye, also represses hRECs in the same environment. TTR is predicted to inhibit the proliferation of hRECs and neovascularization.

Entities:  

Keywords:  diabetic retinal; human retinal microvascular endothelial cells; human retinal pigment epithelial cells; hyperglycemia; hypoxia; transthyretin

Year:  2016        PMID: 27366679      PMCID: PMC4916134          DOI: 10.18240/ijo.2016.06.03

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

1.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Correlation of misfolded transthyretin in abnormal vitreous and high myopia related ocular pathologies.

Authors:  Jun Shao; Yu Xin; Yong Yao
Journal:  Clin Chim Acta       Date:  2011-07-29       Impact factor: 3.786

3.  Polyol effects on growth factors and MAPK signaling in rat retinal capillary cells.

Authors:  Peng Zhang; Zifeng Zhang; Peter F Kador
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-20       Impact factor: 2.671

4.  Vitreous and serum levels of transthyretin (TTR) in high myopia patients are correlated with ocular pathologies.

Authors:  Jun Shao; Yu Xin; Rongxiu Li; Ying Fan
Journal:  Clin Biochem       Date:  2011-03-21       Impact factor: 3.281

5.  Hypoxia post-translationally activates iron-regulatory protein 2.

Authors:  E S Hanson; L M Foot; E A Leibold
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

6.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.

Authors:  H Ozaki; A Y Yu; N Della; K Ozaki; J D Luna; H Yamada; S F Hackett; N Okamoto; D J Zack; G L Semenza; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

Review 7.  Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.

Authors:  Raghu Pullakhandam; Ravindranadh Palika; Sudip Ghosh; Geereddy Bhanuprakash Reddy
Journal:  IUBMB Life       Date:  2012-11-06       Impact factor: 3.885

8.  Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.

Authors:  Raquel J Nunes; Paula de Oliveira; Ana Lages; Jörg D Becker; Paulo Marcelino; Eduardo Barroso; Rui Perdigoto; Jeffery W Kelly; Alexandre Quintas; Susana Constantino Rosa Santos
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

Review 9.  Diabetic retinopathy: more than meets the eye.

Authors:  Thomas W Gardner; David A Antonetti; Alistair J Barber; Kathryn F LaNoue; Steven W Levison
Journal:  Surv Ophthalmol       Date:  2002-12       Impact factor: 6.048

10.  Prevalence of refractive errors and associated risk factors in subjects with type 2 diabetes mellitus SN-DREAMS, report 18.

Authors:  Padmaja Kumari Rani; Rajiv Raman; Sudhir R Rachapalli; Vaitheeswaran Kulothungan; Govindasamy Kumaramanickavel; Tarun Sharma
Journal:  Ophthalmology       Date:  2010-02-16       Impact factor: 12.079

View more
  5 in total

1.  Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy.

Authors:  Jun Shao; Yong Yao
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

2.  PPARδ Inhibits Hyperglycemia-Triggered Senescence of Retinal Pigment Epithelial Cells by Upregulating SIRT1.

Authors:  Eun Ji Lee; Jun Pil Won; Hyuk Gyoon Lee; Eunsu Kim; Jinwoo Hur; Won Jin Lee; Jung Seok Hwang; Han Geuk Seo
Journal:  Antioxidants (Basel)       Date:  2022-06-20

3.  Systemic and vitreous biomarkers - new insights in diabetic retinopathy.

Authors:  Bernardete Pessoa; João Heitor; Constança Coelho; Magdalena Leander; Pedro Menéres; João Figueira; Angelina Meireles; Melo Beirão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-24       Impact factor: 3.535

4.  Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.

Authors:  Jun Shao; Yunbin Zhang; Guangming Fan; Yu Xin; Yong Yao
Journal:  BMC Med Genomics       Date:  2019-10-15       Impact factor: 3.063

5.  Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.

Authors:  Guangming Fan; Yu Gu; Jiaojiao Zhang; Yu Xin; Jun Shao; Francesca Giampieri; Maurizio Battino
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.